Metrics as of 10/15/2026, 10:03 AM (Berlin time), refresh in progress.
Curatis Holding Stock
Curatis Holding AG
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Switzerland
- CEO
- Roland Rutschmann
- Employees
- 9
- Market cap
- CHF93 M
- IPO
- 16/04/1999
- Web
- curatis.com
Curatis Holding AG is a healthcare company headquartered in Liestal, Switzerland. The company specializes in the entire lifecycle of pharmaceutical products, including the procurement, advancement, and market release of medications specifically designed for the diagnosis, prevention, and management of rare and…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Curatis Holding stock: price history
1D
-4.9%
1W
-12.1%
1M
-8.2%
6M
-24.5%
YTD
+45.4%
1Y
+39.6%
2Y
+94.3%
5Y
-94.5%
10Y
-87.0%
Next earnings date
Next earnings date
12/04/2027 (in 177 days)
Volatility around earnings
Not enough history for an assessment
Ask the agents about Curatis Holding
Curatis Holding stock metrics
P/E
-137.29
P/B
1.86
EV/EBITDA
-328.87
RETURN ON EQUITY
-0.8%
NET MARGIN
-5.1%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
21.6%
FLOAT SHARES
1,146,615
AVG. DAILY VOLUME (30D)
2,424
Comparable stocks
Frequently asked questions about Curatis Holding stock
What does Curatis Holding do?
Curatis Holding AG is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Switzerland.
The CEO is Roland Rutschmann, the company employs around 9 people.
The IPO was on 16/04/1999; the stock trades on SIX under the ticker CURN.SW.
When does Curatis Holding report next?
The next earnings date is 12/04/2027.
Does Curatis Holding pay a dividend?
No, Curatis Holding currently does not pay a dividend.
Which stocks are comparable to Curatis Holding?
Comparable stocks include Sandoz Group, Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Curatis Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Curatis Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.